Citalopram
Celexa
Ibogaine and Escitalopram
Also known as: Lexapro
QTc prolongation + serotonergic interaction with noribogaine.
Severity
Contraindicated
Mechanism
QT-interval prolongation
Protocol Status
Onsite supervised taper at MindScape
Restart Delay
14 days
What "Contraindicated" Means
Absolute prohibition without an enforced washout. Treatment cannot proceed safely until the medication has been cleared from the body for the protocol's required interval.
Clinical Action
What our medical team does for patients on Escitalopram.
Onsite supervised taper at MindScape with continuous QTc telemetry and TA booster bridging.
Where the Washout Happens
Onsite supervised taper at MindScape
Patient arrives on the current prescribed dose. The entire taper is conducted onsite under continuous physician supervision and telemetry, supported by twice-daily ibogaine TA (total alkaloid) booster doses where indicated. The HCl flood dose is administered only after titration to the protocol-defined safe threshold.
Post-Treatment Restart
Wait at least 14 days post-treatment before restarting.
The Pharmacology
How Escitalopram interacts with ibogaine: qt-interval prolongation.
Ibogaine and noribogaine block the cardiac hERG (IKr) potassium channel, which lengthens ventricular repolarisation and the QTc interval on a 12-lead EKG. Adding a second QT-prolonging drug compounds the effect and raises the risk of torsades de pointes — a polymorphic ventricular tachycardia that can be fatal. Every patient receives a baseline EKG, electrolyte panel, and continuous cardiac monitoring; medications in this class must be washed out long enough to return QTc into a safe range.
Same Mechanism
Other medications that interact via qt-interval prolongation.
Same Severity Tier
Other contraindicated medications (different mechanism).
Serotonergic activity (serotonin syndrome)
Fluoxetine
Prozac, Sarafem
Serotonergic activity (serotonin syndrome)
Sertraline
Zoloft
Serotonergic activity (serotonin syndrome)
Paroxetine
Paxil, Pexeva
Serotonergic activity (serotonin syndrome)
Fluvoxamine
Luvox
Serotonergic activity (serotonin syndrome)
Vortioxetine
Trintellix, Brintellix
Serotonergic activity (serotonin syndrome)
Vilazodone
Viibryd
Common Questions
Escitalopram and ibogaine treatment.
Can I take ibogaine if I am on Escitalopram?
Contraindicated. QTc prolongation + serotonergic interaction with noribogaine. Onsite supervised taper at MindScape with continuous QTc telemetry and TA booster bridging.
How long do I need to be off Escitalopram before ibogaine treatment?
Onsite supervised taper at MindScape. Patient arrives on the current prescribed dose. The entire taper is conducted onsite under continuous physician supervision and telemetry, supported by twice-daily ibogaine TA (total alkaloid) booster doses where indicated. The HCl flood dose is administered only after titration to the protocol-defined safe threshold. Wait at least 14 days post-treatment before restarting.
What is the mechanism of the interaction?
QT-interval prolongation. Ibogaine and noribogaine block the cardiac hERG (IKr) potassium channel, which lengthens ventricular repolarisation and the QTc interval on a 12-lead EKG. Adding a second QT-prolonging drug compounds the effect and raises the risk of torsades de pointes — a polymorphic ventricular tachycardia that can be fatal. Every patient receives a baseline EKG, electrolyte panel, and continuous cardiac monitoring; medications in this class must be washed out long enough to return QTc into a safe range.
Can I switch to a different medication so I can have ibogaine treatment?
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Escitalopram — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 103 medications in the A–Z directory.
DA
Medically reviewed by Dr. Arellano, M.D.
Clinical Director, MindScape Retreat · Board-certified physician specializing in ibogaine-assisted detoxification with over 900 patients treated.
Last reviewed: May 2026 · See full medical team